[synthesis.]Internal

Regulatory intelligence — not medical or legal advice.

Appearance
Active: dark
Accent
Corner radius
Font
Layout
Data refresh

Runs once per app session in the background and keeps existing data if source APIs are unavailable.

Annotation style
Ask · OpenAI

Requires OPENAI_API_KEY on the server. Heuristics always run first.

← Disease database

malignant parietal pleura tumor

A malignant neoplasm that arises from mesothelial cells in the pleura and shows a diffuse growth pattern. It arises on the parietal and sometimes visceral pleura as multiple small nodules that later become confluent and invade the chest wall adipose tissue and muscle. Asbestos exposure is the main cause for the development of pleural malignant mesothelioma. It usually affects patients over sixty years of age. The latency period is long. Patients usually present with pleural effusion, dyspnea and chest wall pain.

Therapeutic area
Oncology
Rarity
Unknown
Prevalence
MONDO
MONDO:0001861

Overview

A malignant neoplasm that arises from mesothelial cells in the pleura and shows a diffuse growth pattern. It arises on the parietal and sometimes visceral pleura as multiple small nodules that later become confluent and invade the chest wall adipose tissue and muscle. Asbestos exposure is the main cause for the development of pleural malignant mesothelioma. It usually affects patients over sixty years of age. The latency period is long. Patients usually present with pleural effusion, dyspnea and chest wall pain.

Additional signs and symptoms include chills, sweating, weight loss, and weakness. Morphologic variants include epithelioid, desmoplastic, sarcomatoid, and biphasic mesothelioma. The clinical course is usually aggressive.

Content last reviewed: 2026-06